Follow
Nanoform Finland Oy
Nasdaq First North Sweden (Sweden)
Nasdaq First North Finland (Finland)
Nanoform is an innovative nanoparticle medicine enabling company that supplies best in class nanoformingTM services. Our multi-patented CESS® technology can double the amount of lead compounds progressing into clinic, leading to a significant increase in the number of drugs that reach the market. The green particle engineering process produces pure and stable nanoparticles as small as 10 nm using supercritical carbon dioxide.
Sector:
HEALTH CARE
>
Pharmaceuticals
IPO
Price
36.42 SEK
Subscription period
25 May - 02 Jun 2020
View Details
News
Nothing to display for this company
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
NANOFS
FI4000330972
Nasdaq First North Sweden
Sweden (SE)
Details of share in Nanoform Finland Oy with ticker NANOFS
Status
Inactive
Order book id
Amount of instruments
Par value
Market cap
Currency
SEK
Segment
First North Premier
First trading date
04 Jun 2020
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
36.42 SEK
149.7M EUR
25 May - 02 Jun 2020
IPO in Nanoform Finland Oy
Market
Nasdaq First North Sweden
Subscription period
25 May - 02 Jun 2020
Subscription price
36.42 SEK
Price per share
36.42 SEK
Target to raise
70 000 000 EUR
Types
Share issue
Pre-money valuation
149 700 000 EUR
Subscription block size
Minimum subscription
300
Record date
Offer status
Active
Listing status
Upcoming
First trading date
04 Jun 2020
 
Issue terms
Open to the public.
Comments for offer & related information
Preliminarily a maximum of 1 300 000 Offer Shares are being offered in the IPO for subscription by private individuals and entitites in Finland and Sweden.
The company issues 20 289 856 new shares for EUR 70 millions and selling 2 318 605 of existing shares for EUR 8.44 millions.
Furthermore, a targeted issue of EUR 10 million may be made in an over-allotment option. Keel Capital, Fourth AP Fund (AP4), Handelsbanken Fonder AB, some funds managed by Sp-Fund Management Company Ltd, Mandatum Life Insurance Company Limited (part of Sampo Group), some funds managed by OP Fund Management Company Ltd, and Avohoidon Tutkimussäätiö (jointly "Cornerstone Investors") each in May 2020, subject to certain conditions, undertook to subscribe for shares totaling approximately EUR 45.5 million in the Offer.
Comments for listing & related information
In mid-May 2020, Nanoform announced that they will make an IPO and list their shares on First North in Finland and Sweden.
Anchor investors have committed to subscribe for EUR 45 million, these are Keel Capital, Fourth AP Fund (AP4), Handelsbanken Fonder AB, some funds managed by Sp-Fund Management Company Ltd, Mandatum Life Insurance Company Limited (part of Sampo Group ), some funds managed by OP Fund Management Company Ltd, and Avohoidon Tutkimussäätiö.
Danske Bank A / S, Finland Branch and Scandinavian Enskilda Banken AB are Joint Global Coordinators and Swedbank AB (in collaboration with Kepler Cheuvreux SA) and Stifel Nicolaus Europe Limited are Joint Bookrunners in connection with the listing.
Update (25.05.2020): Nanoform will be listed on Nasdaq Stocholm First North Growht market and Nasdaq Helisnki First North Growth market on June 4, 2020.
Type
Ticker
ISIN
Market
SHARE
NANOFH
FI4000330972
Nasdaq First North Finland
Finland (FI)
Details of share in Nanoform Finland Oy with ticker NANOFH
Status
Inactive
Order book id
Amount of instruments
Par value
Market cap
Currency
EUR
First trading date
04 Jun 2020
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
3.45 EUR
149.7M EUR
25 May - 02 Jun 2020
IPO in Nanoform Finland Oy
Market
Nasdaq First North Sweden
Subscription period
25 May - 02 Jun 2020
Subscription price
3.45 EUR
Price per share
3.45 EUR
Target to raise
70 000 000 EUR
Types
Share issue
Pre-money valuation
149 700 000 EUR
Subscription block size
Minimum subscription
300
Record date
Offer status
Active
Listing status
Upcoming
First trading date
04 Jun 2020
Issue terms
Open to the public.
Comments for offer & related information
Preliminarily a maximum of 1 300 000 Offer Shares are being offered in the IPO for subscription by private individuals and entitites in Finland and Sweden.
The company issues 20 289 856 new shares for EUR 70 millions and selling 2 318 605 of existing shares for EUR 8.44 millions.
Furthermore, a targeted issue of EUR 10 million may be made in an over-allotment option. Keel Capital, Fourth AP Fund (AP4), Handelsbanken Fonder AB, some funds managed by Sp-Fund Management Company Ltd, Mandatum Life Insurance Company Limited (part of Sampo Group), some funds managed by OP Fund Management Company Ltd, and Avohoidon Tutkimussäätiö (jointly "Cornerstone Investors") each in May 2020, subject to certain conditions, undertook to subscribe for shares totaling approximately EUR 45.5 million in the Offer.
Comments for listing & related information
In mid-May 2020, Nanoform announced that they will make an IPO and list their shares on First North in Finland and Sweden.
Anchor investors have committed to subscribe for EUR 45 million, these are Keel Capital, Fourth AP Fund (AP4), Handelsbanken Fonder AB, some funds managed by Sp-Fund Management Company Ltd, Mandatum Life Insurance Company Limited (part of Sampo Group ), some funds managed by OP Fund Management Company Ltd, and Avohoidon Tutkimussäätiö.
Danske Bank A / S, Finland Branch and Scandinavian Enskilda Banken AB are Joint Global Coordinators and Swedbank AB (in collaboration with Kepler Cheuvreux SA) and Stifel Nicolaus Europe Limited are Joint Bookrunners in connection with the listing.
Update (25.05.2020): Nanoform will be listed on Nasdaq Stocholm First North Growht market and Nasdaq Helisnki First North Growth market on June 4, 2020.
People
Edward Hæggström
CEO
Miguel Calado
Chairman of the board
Mads Laustsen
Board member
Albert Hæggström
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Viikinkaari 4
Zip code
FI-00790
City/district
HELSINKI
Country
Finland (FI)
Registration number
2730572-8
LEI code
743700JJO2NU8LBS1592
First trade date
04 Jun 2020
Registration date
07 Dec 2015
Short name
Nanoform

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date